Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium.
Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Louvain-la-Neuve, Belgium.
Nat Commun. 2024 Nov 21;15(1):10107. doi: 10.1038/s41467-024-54435-3.
Cancer cells in acidic tumor regions are aggressive and a key therapeutic target, but distinguishing between acid-exposed and hypoxic cells is challenging. Here, we use carbonic anhydrase 9 (CA9) antibodies to mark acidic areas in both hypoxic and respiring tumor areas, along with an HRE-GFP reporter for hypoxia, to isolate distinct cell populations from 3D tumor spheroids. Transcriptomic analysis of CA9-positive, hypoxia-negative cells highlights enriched fatty acid desaturase activity. Inhibiting or silencing stearoyl-CoA desaturase-1 (SCD1) induces ferroptosis in CA9-positive acidic cancer cells and delays mouse tumor growth, an effect enhanced by omega-3 fatty acid supplementation. Using acid-exposed cancer cells and patient-derived tumor organoids, we show that SCD1 inhibition increases acidic cancer cell reliance on external mono-unsaturated fatty acids, depriving hypoxic cells of essential resources. This bystander effect provides unbiased evidence for a lack of full overlap between hypoxic and acidic tumor compartments, highlighting a rationale for targeting desaturase activity in cancer.
酸性肿瘤区域的癌细胞具有侵袭性,是一个重要的治疗靶点,但区分暴露于酸性环境和缺氧的细胞具有挑战性。在这里,我们使用碳酸酐酶 9(CA9)抗体标记缺氧和呼吸肿瘤区域的酸性区域,以及 HRE-GFP 报告基因来标记缺氧,从 3D 肿瘤球体中分离出不同的细胞群体。对 CA9 阳性、缺氧阴性细胞的转录组分析突出了富含脂肪酸去饱和酶活性。抑制或沉默硬脂酰辅酶 A 去饱和酶-1(SCD1)可诱导 CA9 阳性酸性癌细胞发生铁死亡,并延迟小鼠肿瘤生长,而添加 ω-3 脂肪酸可增强这种作用。使用暴露于酸性的癌细胞和患者来源的肿瘤类器官,我们表明 SCD1 抑制增加了酸性癌细胞对外部单不饱和脂肪酸的依赖,剥夺了缺氧细胞的必要资源。这种旁观者效应为缺氧和酸性肿瘤区室之间没有完全重叠提供了无偏倚的证据,突出了在癌症中靶向去饱和酶活性的合理性。